Status:
TERMINATED
Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study consists of a prospective clinical trial which aims to evaluate the impact of stent insertion for palliation of malignant dysphagia. The main goal being to examine the number of days requir...
Detailed Description
Esophageal cancer is one of the 10 most frequent cancers in the world. The incidence of esophageal cancer is rapidly increasing and is doing so at a more rapid rate than any other cancer in the wester...
Eligibility Criteria
Inclusion
- All patients with end stage inoperable esophageal cancer deemed candidates for intraluminal esophageal palliative stent insertions.
Exclusion
- Inability to consent for the study.
- Patients less than 18 years old.
- Patients with other benign causes of dysphagia and esophageal obstruction or stenosis.
- Patients with malignant or benign airway - esophageal fistulas.
- Patients with cervical esophageal cancer
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 6 2018
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01471249
Start Date
June 1 2011
End Date
April 6 2018
Last Update
September 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2L 4M1